3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
19
Thyroid Neoplasms
6
Glioma
6
Thyroid Carcinoma, Anaplastic
5
Multiple Myeloma
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Thyroid Cancer, Papillary
3
Hematologic Neoplasms
3
Skin Neoplasms
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Histiocytosis, Langerhans-Cell
2
Glioblastoma
2
Colonic Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Adenocarcinoma, Follicular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid cancer, follicular
1
Thyroid cancer, Hurthle cell
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Sarcoma
1
Interventions
Carboplatin
47
Etoposide
46
durvalumab
28
atezolizumab
28
Cisplatin
21
Topotecan
19
pembrolizumab
15
PM 01183
15
Nivolumab
12
Specimen Handling
11
anlotinib
9
Radiotherapy
9
Paclitaxel
9
Drug Therapy
9
Temozolomide
8
Magnetic Resonance Spectroscopy
8
AMG 757
8
Radiosurgery
7
Platinum
7
Irinotecan
7
toripalimab
6
olaparib
6
Biopsy
6
Ipilimumab
5
Injections
5
Docetaxel
5
Bevacizumab
5
trilaciclib
4
tremelimumab
4
tislelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
dabrafenib
×
1 year
×
Clear all
No trials found.